Monthly Archives: January 2015

Chart Of The Day – Cempra (CEMP)

The Chart of the Day is Chart of the Day  (CEMP).  I found the pharmaceutical company by sorting the All Time High list for the stock having the most frequent new highs in the last month.  Since the Trend Spotter signaled a buy on 11/26 the stock gained 69.65%, Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for…

Yenny For Your Thoughts

Today was the most profitable day I’ve had in a long time … at least a year, I think … and “stay the course” doesn’t make for very compelling content. But I’m going to try … I will state that I remain very short the market, highly concentrated in commodities and energy. Yes, I took…

The Dirtiest Word In Startups

Just as karaoke machines created a nation of wannabe singers, and WordPress created a nation of wannabe writers, so the imperfect storm of global connectivity, crowd-funding, and America’s protracted economic and employment malaise (aka Lagflation) have created a nation of wannabe entrepreneurs. While there are many articles out there urging you to throw caution to…

Airline Stocks Flying High In 2015

One of the major input costs for airlines is fuel, and with oil prices hitting multi-year lows, airlines will subsequently start to see improved operating margins.  Further, the length at which oil prices have been subdued is significantly aiding airline company’s top and bottom lines for at least Q4 2014, and Q1 2015. As we…

Goldman’s 2015 S&P 500 Trajectory In 1 Chart: Drop, Pop

Not satisfied with merely “nailing the number”, Goldman Sachs’ David Kostin forecasts the S&P 500’s trajectory through 2015. Recognizing, as we did, that Bullish Sentiment is as highs as it gets, Kostin expects short-term weakness during the next month (the drop), earnings growth thanks to lower oil prices into mid-year (the pop), but multiple compression…

Taking Stock Of The Q4 Earnings Season

The 2014 Q4 earnings season takes center stage from next week onwards even though the reporting cycle has actually been underway for a couple of weeks. The reports thus far (17 S&P 500 companies have reported results) are from companies with fiscal quarters ending in November, which we count as part of the Q4 tally….

E

Shares of Isis Pharmaceuticals (ISIS) soared as much as 10% in today’s trading session after the company had announced the collaboration deal with Janssen Biotech, a unit of Johnson & Johnson (JNJ). According to the deal, both companies will co-develop RNA drugs targeting autoimmune diseases of the GI tract. Autoimmune diseases occurs when the patient’s…